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Abstract 
Purpose: To investigate the immunoregulative effects of ulinastatin (UTI) on T lymphocytes apoptosis 
in rats with severe acute pancreatitis (SAP) and to elucidate its underlying molecular mechanism.  
Methods: Thirty six Wistar rats were randomly divided into 3 groups (n =12): sham, SAP model and 
UTI-treated group. SAP model was established by intrapancreatobiliary duct injection of 5% sodium 
taurocholate. A bolus of 10000 U/kg UTI was intravenously injected after SAP establishment. T cell 
apoptosis was determined by Annexin-V/PI double-staining. Oxidative stress was evaluated by 
examining changes in the levels of reactive oxygen species (ROS). Total superoxide dismutase (SOD) 
in serum was tested by hydroxylamine colorimetric assay, and malondialdehyde levels were examined 
by thiobarbituric acid assay. Mitochondrial function was evaluated by analyzing mitochondrial 
membrane potential (MMP) and mitochondrial permeability transition pore (MPTP).  
Results: We found CD4+ T cells (32.10±2.87% vs. 45.22±4.38%, P<0.01) and CD4+/CD8+ T cells in SAP 
rats significantly decreased compared with sham group (1.15±0.12 vs. 2.23±0.12%, P<0.01), while the 
percent of the apoptotic CD4+ and (17.70±2.10 vs. 3.82±0.50%, P<0.01) CD8+ T lymphocytes was highly 
increased (2.78±0.45 vs. 1.97±0.36%, P<0.01 compared with sham group). After UTI treatment, the 
apoptosis of CD4+ T lymphocytes significantly decreased compared with SAP group (8.58±1.09 vs. 
17.70±2.10%, P<0.01), while the percent of CD4+ T and CD4+/CD8+ lymphocytes significantly enhanced 
(P<0.01). ROS (mean fluorescence intensity): 5107±430 vs. 12904±840, P<0.01) and MDA levels 
(4.41±0.32 vs. 7.25±0.57nmol/ml, P<0.01) in serum in UTI-treated group were decreased compared 
with SAP group. SOD activity was enhanced after UTI treatment (59.72±5.45 vs. 48.32±3.81nmol/ml, 
P<0.01). Mitochondrial function assays showed that MMP (17.30±1.60 vs. 46.94±3.49%, P<0.01) and 
MPT (30.14±2.46 vs. 51.31±3.23%, P<0.01) were inhibited by UTI.  
Conclusion: UTI reduces T lymphocytes apoptosis and improves immunological function in SAP rats, 
possibly via enhancing the scavenging capacity of oxygen free radical and attenuating the influence of 
oxidative stress. 
 
Key words: Ulinastatin, T cell, Apoptosis, Severe acute pancreatitis, Mitochondrion. 
  
 
Tropical Journal  of Pharmaceutical Research is indexed by Science Citation Index (SciSearch), Scopus, 
International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African 
Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals 




Severe acute pancreatitis (SAP) is a systematic 
disease with ongoing immune disorder. In the 
early stage, it is characterized by overdue 
inflammatory reaction, with its major clinical 
manifestation of systematic immune syndrome 
(SIRS) and the functional damage of related 
organs like cardiovascular, lungs and kidney [1]. 
In the late stage, the severe suppression of 
immune function is the fundamental cause of 
infection [2], which is manifested by disproportion 
of CD4/CD8, T helper cell (Th1/Th2) shift, the 
anergy of lymphocytes and most prominently, the 
excessive apoptosis of lymphocytes. The 
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excessive apoptosis of lymphocytes is the critical 
link that causes the dysfunction of immune 
system. Large amount of scavenging by the 
apoptosis of lymphocytes attenuates the number 
of lymphocytes with biological activity.  
 
It has been demonstrated that oxidative stress 
(OS) is closely related to lymphocyte apoptosis 
[3]. As the fundamental organelles to determine 
the destiny of cells [4], mitochondria are the 
target of the ROS injury and an important origin 
of ROS as well [5].  
 
Ulinastatin (UTI) is the glycoprotein separated 
and purified from the urine of healthy adult men. 
As an endogenous protective mechanism, UTI 
can antagonize stress and attenuate organ 
injury. Researchers have demonstrated that UTI 
has a strong enzyme inhibitory activity [6], 
enabling it to inactivate multiple enzymes. 
Furthermore, UTI has anti-inflammatory activity 
and can directly inhibit inflammatory mediators 
and inflammatory cytokines such as TNF-α, IL-1 
and IL-8 [7]. Therefore, UTI is widely applied to 
pancreatitis therapy due to its ability to reduce 
many critical factors including the pancreative 
activity and the release of inflammatory 
mediators [8].  
 
It has also been suggested that UTI improves 
immune function [9]. Given the therapeutical 
value of UTI and ROS production [10], we 
assumed that UTI may exert immunoinhibitory 
effects on SAP. In the present study, we 
investigated the immunoregulatory effects of UTI 
on T lymphocytes apoptosis in SAP rat model 
and elucidated the underlying molecular 
mechanism. 
 




Thirty six Wistar rats (250-300g, 3 months old, 18 
males and 18 females), were purchased from 
Animal Laboratory Centre, Academy of Military 
Medical Sciences of PLA (license: SCXK 2009-
003). Animals were kept in clean separate cages 
with free access to food and water, where room 
temperature remained between 20℃ to 29℃ in 
the dry aeration atmosphere, for 12 hours under 
fluorescent illumination to maintain the diurnal 
cycle. All the animal experiments were performed 
in accordance with the guidelines for animal 
research from the National Animal Center of 
China (No.95-38, revised 1995). All experimental 
protocols were approved by the Animal Care and 
Use Committee of Tianjin Medical University and 
were conducted according to the Helsinki 
Declaration.  
Animal grouping and establishment of SAP 
model 
 
Rats were randomly divided into 3 groups (n=12) 
after one week of adaptive feed: (1) sham-
operated control group; (2) SAP group; (3) UTI-
treated group. Animals were fasted for 12 hours 
before operation, with free access to water. Each 
rat was intraperitoneally administered with 10% 
chloral hydrate according to the weight that is, 
300mg/kg. Abdominal skin preparation and 
disinfection was given after anesthesia. Then 
central abdominal incision below the xiphoid 
process was made under aseptic operation. The 
lower margin of the liver, the duodenum, the 
pancreatic duct and the partial pancreas were 
exposed. Puncture was carried out using 
disposable IV catheter through the lateral wall on 
the duodenum where the two 
cholecystopancreatic ducts form an opening. 
Part of the needle core was withdrawn 
immediately after insertion into the duodenal 
cavity. Then the trocar enters approximately 0.5 
cm along the opening of the 
cholecystopancreatic duct and the needle core 
was completely pulled out. Cholecystopancreatic 
duct in the hilar region was clamped with a 
microclip to prevent the sodium taurocholate 
from injecting into the liver and the end of the 
intubation was connected to the syringe pump. 
 
In the SAP model group and UTI-treated group, 
animals were injected with 5% sodium 
taurocholate at the speed of 0.1 ml/min 
according to the weight that is, 1ml/kg. Five 
minuites after injection, the intubation and artery 
occlusion were removed and the pin hole was 
wiped on the duodenal wall with 100% alcohol to 
make it contract to prevent the outflow of the 
intestinal contents. In the sham group, injection 
of sodium taurocholate was excluded. Other 
operations are the same as the other two groups. 
After operation, animals in each group recieved 
the interval subcutaneous injection of 5% 
glucose and sodium oxide of 50ml/kg. Following 
the development of the SAP model, animals in 
the UTI-treated group received injection of UTI 
through the tail vein of 10000 U/kg. All the 
animals were taken postoperative insulation and 
incision care to avoid asphyxia death caused by 
the rats’ scratching and biting the suture or their 
vomit.  
 
Separation of spleen lymphocytes 
 
Suspensions of spleen T cells were cultured at a 
density of 2×105/well in RPMI 1640 medium 
supplemented with 5% heat-inactivated fetal 
bovine serum, 2 mM L-glutamine, 100 U/ml 
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penicillin and 100 µg/ml streptomycin in a 
humidified incubator, at 37°C with 5% CO2.  
MagCellect rat CD3+ T cell isolation kit 
(R&DSystems, Minneapolis, MN, USA) was used 
according to the manufacturer's recommendation 
to isolate splenic T cells (C3H).Then, these were 
stained with FITC-conjugated anti-CD4 or PE-
conjugated anti-CD8 antibody (BD Biosciences 
PharMingen). 
 
Analysis of T cell apoptosis by flow 
cytometry  
 
T cells were harvested and resuspended in 
binding buffer. The cell suspension was 
incubated with FITC Annexin-V (BD Biosciences, 
USA) and propidium iodide (PI) for 15 min at 
room temperature in dark followed by flow 
cytometry analysis. The percentage of cells 
positive for Annexin-V, PI alone and in 
combination was calculated by dot plot analysis 
using Cell Quest Pro software (FCM-500, 
Beckman). 
 
Determination of malondialdehyde (MDA) 
production and superoxide dismutase (SOD) 
activity  
 
The levels of SOD and MDA, special markers for 
reactive oxygen species (ROS), were determined 
in the sera of mice. The MDA level and SOD 
activity were analyzed using specific reagents 
according to the protocols provided by the 
manufacturer (Nanjing Jiancheng Bioengineering 
Institute, China). Briefly, thiobarbituric acid was 
used as substrate for the detection of MDA, and 
the xanthine oxidase method was used for the 
detection of SOD activity.  
 
Mitochondrial membrane potential assay 
 
An reagent, 5,5’,6,6’- tetrachloro-1,1’,3,3’ 
tetraethylbenzimidazoly-carbocyanine iodide (JC-
1), was used to assess mitochondrial potential 
changes using confocal microscope. Briefly, cells 
in 24-well plates at a density of 1×105 cells/ml 
cultured at 37C overnight for 24 hrs before 
addition of 1 µg/ml JC-1 in culture media for 30 
min. The cells were examined by confocal 
microscope (Nikon, Japan). Changes in the 
fluorescence from red to green indicate the 
changes in mitochondrial membrane potential; 
the green/red ratio was calculated from the 
changes in the intensity of red and green 
fluorescence assessed using a computer 
program. 
 
Determination of mitochondrial permeability 
transition 
 
Mitochondrial permeability transition was 
determined by MitoProbe transition pore assay 
kit (Molecular Probes Inc., Eugene, OR, USA), a 
technique based on calcein acetoxymethyl ester 




The data was analyzed with SPSS18.0 software. 
The measurement data was expressed as X±S, 
the multiple mean comparison was evaluated by 
one way ANOVA, and the comparison between 
any two means by LSD test. The significant 




Ratio of CD4+ to CD8+ T cell subsets 
 
As shown in Table 1, we found the percents of 
CD4+ T cells (32.10 ± 2.87 % vs. 45.22 ±4.38 %, 
p < 0.01) and CD4+/CD8+ T cells in SAP rats 
significantly decreased compared with sham 
group (1.15 ± 0.12 vs. 2.23 ± 0.12 %, p < 0.01)  
 
Table 1: Ratio of CD4+ to CD8+ T cell subsets in each 
group (n = 12) 
 
Group  CD4+(%)   CD8+(%) CD4+/CD8+ 
Sham 45.22±4.38 20.28±2.11 2.23±0.12 
SAP 32.10±2.87* 28.41±2.31 1.15±0.12* 
Ulinastatin 37.63±3.41# 24.31±2.62 1.66±0.12# 
All the values are given as mean ± SEM; * p < 0.01 vs. 
control group；# P < 0.01 vs. SAP group 
 
Ratio of CD4+ to CD8+ T cell subset apoptosis 
 
By using annexin V/PI Double Staining, we 
observed that the percent of apoptotic CD4+ T 
cells and (17.70 ± 2.10 vs. 3.82 ± 0.50 %, p < 
0.01) apoptotic CD8+ T cells in the SAP group 
greatly increased (2.78 ± 0.45 vs. 1.97 ± 0.36 %, 
p < 0.01) in comparison with sham group. After 
UTI treatment, the apoptosis of CD4+ T 
lymphocytes in the SAP rats significantly 
decreased (8.58 ± 1.09 vs. 17.70 ± 2.10 %, p < 
0.01), but the percent CD4+ T and CD4+/CD8+ 
lymphocytes markedly enhanced (p < 0.01). 
(Table 2). 
 
ROS Level in spleen lymphocytes 
 
As seen from Table 3, ROS (MFI: 5107±430 vs. 
12904±840, P<0.01) and MDA levels (4.41±0.32 
vs. 7.25±0.57nmol/ml, P<0.01) in serum in UTI-
treated group were decreased. SOD activity was 
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enhanced after UTI treatment (59.72±5.45 vs. 
48.32±3.81 nmol/ml, P<0.01) (Table 4).  
 
Table 2: Apoptosis of CD4+、CD8+ T cells subsets 
in each group (n = 12) 
 
Group 
CD4+ T cells  
subset 
apoptosis (%) 




Control 3.82±0.50 1.97±0.36 
SAP 17.70±2.10* 2.78±0.45* 
Ulinastatin 8.58±1.09# 2.46±0.36▲ 
All the values are given as mean ± SEM; *p < 0.01 vs. 
control group; # p < 0.01 vs. SAP group; ▲p > 0.05 vs. 
SAP group 
 
Table 3: ROS level in spleen lymphocytes for 
each group (n = 12) 
 




All values are given as mean ±SEM; * p < 0.01 vs. 
control; # p < 0.01 vs. SAP group 
 
Table 4: Serum SOD activity and MDA level for 
each group (n=12) 
 
Group SOD activity (U/ml)` 
MDA level 
(nmol/ml) 
Sham 80.68±0.50 2.27±0.26 
SAP 48.32±3.81* 7.25±0.57* 
Ulinastatin 59.72±5.45# 4.41±0.32# 
All the values are given as mean ± SEM; * p < 0.01 vs. 
control group; #p < 0.01 vs. SAP group 
 
Spleen lymphocyte MMP 
 
Mitochondrial function was evaluated by 
analyzing mitochondrial membrane potential. It 
showed that MMP (17.30 ± 1.60 vs. 46.94 ± 3.49 
%, p < 0.01) (30.14±2.46 vs. 51.31±3.23 %, p < 
0.01) was inhibited by UTI (Table 5). 
 
Table 5: The spleen lymphocyte MMP for each 
group (n = 12) 
 




All the values are given as mean ± SEM; * p < 0.01 vs. 
control group; #p < 0.01 vs. SAP group 
 
Opening level of the spleen lymphocyte 
MPTP 
 
Mitochondrial function was also evaluated by 
analyzing by mitochondrial permeability transition 
pore. As shown in Table 6, compared with SAP 
group, MPT (30.14 ± 2.46 vs. 51.31 ± 3.23 %, p 
< 0.01) was inhibited in UTI-treated rats.  
 
Table 6: Opening level of the spleen lymphocyte 









All the values are given as mean ± SEM; * p < 0.01 




UTI attenuates the abnormal apoptosis of 
CD4+ T lymphocytes in SAP rats 
 
Lymphocyte apoptosis is closely related 
immunosuppression [11]. Recent study has 
proved that immunosuppression is mainly 
caused by acceleration of lymphocytes 
apoptosis. Inflammation of the pancreas and its 
surrounding areas, caused by weakened 
immunity, is the commonest and severest 
complication and constitutes the main cause of 
death in the later progress of SAP, with mortality 
rate reaching 80% [12]. 
 
In our study, the percentage of apoptotic CD4+T 
lymphocytes in the SAP group went up more 
noticeably than that of apoptotic CD8+T 
lymphocytes, which led to the phenomenon that 
the percentage of CD4+T lymphocytes and the 
ratio of CD4+ and CD8+T lymphocytes in SAP 
group were remarkably lower than that in sham 
operation control group. It can be concluded that 
when SAP occurs, the body stimulates the 
apoptosis of CD4+T lymphocytes to down-
regulate inflammatory reaction. This can lighten 
the injury that resulted from excessive 
inflammatory reaction but will result in low 
cellular immune function which causes 
immunosuppression. 
 
UTI, a glycoprotein secreted by the liver [13], can 
act on several key steps of pancreatic disease, 
such as activation of pancreatic enzymes and 
cytokines and release of inflammatory mediators, 
so it is widely applied in pancreatitis treatment 
[8]. In 2009, Huang et al demonstrated UTI can 
noticeably improve the living conditions of sepsis 
patients [14].  
 
In this study, the proportion of CD4+T 
lymphocytes and ratio of CD4+ and CD8+T 
lymphocytes in UTI-treated group has obviously 
picked up compared with the SAP group, mainly 
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due to the fact that the percentage of apoptotic 
CD4+T lymphocytes decreased significantly while 
the proportion of apoptotic CD8+T lymphocytes 
was almost the same with that in the SAP group. 
Through reducing abnormal apoptosis of CD4+T 
lymphocytes in SAP rats, UTI has a direct effect 
in improving the state of immunodepression so 
as to reduce the susceptibility of secondary 
infection, prevent occurrence of septicopyemia 
and MODS and lower the mortality rate of SAP. 
 
UTI attenuates oxidative stress level in rats 
with SAP 
 
During the process of pancreatic damage, ROS 
can not only peroxidize fatty acids, but also 
destroy the lipid membrane and lysosomal 
membrane, causing injury to the gland. 
Moreover, in the cases of peripancreatic injury, 
ROS is the key factor which generates cytokines 
and inflammatory mediator cascade, mediates 
inflammatory cell infiltration, endothelial 
dysfunction and microcirculation dysfunction, 
thereby resulting in organ lesions. ROS level is 
closely related to the degree of apoptosis the 
lymphocytes [3].  
 
The following reasons may mainly account for 
the increase of oxygen free radical in SAP: Bile 
salts, trypsin and chymotrypsin activate xanthine 
oxidase, which catalyzes the oxidation of 
hypoxanthine to xanthine and produce a great 
number of oxygen free radicals [15]. 
Inflammatory mediators like thromboxane can 
engender neutrophil chemotaxis and produce 
oxygen free radicals through respiratory burst. 
 
SOD can effectively scavenge superoxide anion 
radicals produced in the metabolic process, 
whose activity can indirectly reflect the body’s 
ability to eliminate the oxygen free radicals. MDA 
is one of the major aldehyde formed via lipid 
peroxidation, whose contents can reflect the 
degree of the body’s lipid peroxidation and 
indirectly reflect the severity of oxygen free 
radicals’ attack on cells. Therefore the SOD 
activity and the MDA contents can reflect the 
equilibrium condition between the body’s 
oxidation and anti-oxidation. 
 
The present study showed that UTI can resist 
lipid peroxidation induced by free radicals and 
their metabolic products. Furthermore, as a high 
efficiency, broad spectrum enzyme inhibitor, UTI 
can block the accumulation of neutrophils 
mediated by protease in lungs, inhibit the activity 
and the phagocytosis of the lysosomal enzyme in 
neutrophils, hence reducing the release of 
inflammatory mediators and oxygen free radicals 
and restricting the vicious cycle and magnified 
effect due to the cascade reaction of enzyme, 
cytokine and oxygen free radical. This study 
shows that UTI can significantly enhance the 
scavenging capacity of oxygen free radical, 
reduce the apoptotic ratio of lymphocytes, and 
attenuate the influence of oxidative stress on 
immunologic function in SAP rats through 
lowering the intracellular ROS production in 
splenic lymphocytes and the MDA contents in 
serum, and increasing the activity of SOD in 
serum as well. 
 
The mitochondrial mechanism of UTI 
underlying its role of reducing apoptosis of T 
lymphocytes 
 
Mitochondria are not only the place for 
tricarboxylic acid cycle, oxidative phosphorylation 
and fatty acid oxidation, but also a crucial 
organelle for apoptosis [16]. As a key organelle 
[4] which could decide a cell’s fate--- survival or 
apoptosis, mitochondrion is both the damage 
target point and significant source of ROS [5]. 
Though it is the main place for the generation of 
ROS, excessive ROS could result in the damage 
of mitochondrial oxidative stress and respiratory 
chain dysfunction, which will in reverse stimulate 
mitochondria to produce more ROS. This vicious 
circle could gradually lead mitochondria to 
dysfunction and finally damage cell function and 
viability [17]. Data shows that mitochondrion is 
also a vital source for ROS in T lymphocyte. 
Large quantities of energy is needed for T 
lymphocyte to activate and proliferate, which 
could cause over polarization of mitochondrial 
membrane and further fierce oxidative 
phosphorylation, and more electrons overflow 
from the respiratory chain to bring more ROS 
[18]. The accumulated ROS in mitochondrion 
could result in its DNA mutation, lipid 
peroxidation and open-up MPTP, which could 
finally affect its structure and function. According 
to some studies, the key factors which could 
open up MPTP are excessive Ca2+ in 
mitochondria, oxidative stress after massive 
oxygen radicals, the exhaustion of adenine 
nucleotide and mitochondrial membrane 
depolarization [19]. If the vicious cycle between 
ROS and mitochondria keeps going, cytochrome 
C will be released to activate the cascade of 
caspase-9, 8, 3 enzymes, which finally result in 
lymphocyte apoptosis. During apoptosis, ROS 
stimulates the opening up of MPTP and can also 
be produced as products during this stimulation. 
Hausenloy DJ,et al reported that MPTP may acts 
as a terminal effect factor regulating apoptosis, 
both as endogenous self activator and ROS 
initiation factors [20]. 
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In this experiment, compared with the control 
group, lymphocytes with dropped mitochondrial 
membrane potential or abnormally opened MPTP 
from the SAP group got accelerated remarkably, 
which suggested that, during SAP, splenic 
lymphocytic mitochondrial membrane 
permeability enhanced and potentially 
decreasing, the mitochondrial apoptosis pathway 
played an important role in regulating apoptosis. 
UTI could effectively protect mitochondria 
through stabilizing mitochondrial membrane 
structure and enhancing the activity of 
mitochondrial Na+-K+-ATPase enzyme. Other 
studies found that UTI could lessen mitochondrial 
damages and inhibit apoptosis induced by 
mitochondrial pathway, through limiting the 
expressions of ischemia-reperfusion organic 
cytochrome C and AIF. During the experiment, it 
was found that ulinastatin could dramatically 
lower the ratio of lymphocytes with opened 
MPTP in SAP rats and the ratio with dropped 
MMP. It is finally demonstrated that UTI 
attenuates lymphocytes apoptosis and improves 
immunological function in SAP rats. It exerts the 
therapeutic effects through reducing ROS 
induced by SAP, blocking the vicious cycle 
between ROS and mitochondrial damage, 
thereby inhibiting the apoptosis induced by 
mitochondrial signaling pathways. 
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